Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 6/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29733250 | 0.93 | CALCRL (0.47) | XIAPSLC6A2CAPN1CALCRLSTAT3 | |
| SCHEMBL30441296 | 0.89 | XIAP (0.52) | XIAPSLC6A2CAPN1CTSBCALCRL | |
| SCHEMBL29590865 | 0.88 | XIAP (0.50) | XIAPCALCRLCTSD | |
| SCHEMBL31031582 | 0.87 | XIAP (0.48) | XIAPSLC6A2CAPN1CTSBCALCRL | |
| SCHEMBL31182552 | 0.85 | BACE1 (0.47) | SLC6A2CAPN1CTSBCALCRLSTAT3 | |
| SCHEMBL29733288 | 0.85 | CALCRL (0.51) | XIAPSLC6A2CALCRLSTAT3CTSD | |
| SCHEMBL30123263 | 0.84 | SLC6A2 (0.52) | XIAPSLC6A2CAPN1CTSBCALCRL | |
| SCHEMBL30390685 | 0.84 | XIAP (0.55) | XIAPSLC6A2CAPN1CTSBCALCRL | |
| SCHEMBL29630464 | 0.84 | LMNA (0.43) | XIAPSLC6A2F2F10PRSS1 | |
| SCHEMBL31655493 | 0.84 | BACE1 (0.49) | XIAPSLC6A2CAPN1CTSBCALCRL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |